Global Patent Index - EP 0644765 A4

EP 0644765 A4 19970226 - TREATMENT OF CELLULAR HYPERPROLIFERATION BY INHIBITION OF INTERLEUKIN-1.

Title (en)

TREATMENT OF CELLULAR HYPERPROLIFERATION BY INHIBITION OF INTERLEUKIN-1.

Title (de)

BINDEMITTEL ENTHALTENDE METALLPULVERZUSAMMENSETZUNGEN FÜR HOCHTEMPERATURVERDICHTUNG.

Title (fr)

TRAITEMENT DE L'HYPERPROLIFERATION CELLULAIRE PAR INHIBITION DE L'INTERLEUKINE-1.

Publication

EP 0644765 A4 19970226 (EN)

Application

EP 93914110 A 19930521

Priority

  • US 9304917 W 19930521
  • US 88773492 A 19920522

Abstract (en)

[origin: WO9324134A1] Methods of treating conditions characterized by cellular hyperproliferation using Interleukin-1 inhibitory compounds and compounds useful in the described methods are provided.

IPC 1-7

A61K 31/70; C07H 15/12; C07H 17/00

IPC 8 full level

C12N 15/09 (2006.01); A61K 31/70 (2006.01); A61K 48/00 (2006.01); A61P 1/00 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01); C12N 15/113 (2010.01)

CPC (source: EP KR)

A61K 31/70 (2013.01 - EP KR); A61P 1/00 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07H 15/12 (2013.01 - KR); C12N 15/1136 (2013.01 - EP); C12N 2310/15 (2013.01 - EP); C12N 2310/3125 (2013.01 - EP)

Citation (search report)

  • [X] WO 8906702 A1 19890727 - CHEMEX PHARMACEUTICALS INC [US]
  • [A] WO 9115226 A1 19911017 - AMERICAN NAT RED CROSS [US]
  • [XP] WO 9221353 A1 19921210 - GENTA INC [US]
  • [XP] WO 9305071 A1 19930318 - IMMUNEX CORP [US]
  • [DA] HAMMERBERG, C. ET AL.: "Interleukin - 1 receptor antagonist in normal and psoriatic epidermis.", JOURNAL OF CLINICAL INVESTIGATION, (1992 AUG) 90 (2) 571-83., XP000615300
  • [A] MANSON, J. ET AL.: "Modulation of interleukin 1beta gene expression using antisense phosphorothioate oligonucleotides", LYMPHOKINE RES. 9 (1990);35-42, XP002021245
  • [T] MILLER, K. ET AL.: "In vitro transdermal flux and tissue distribution of interleukin 1-beta antisense methyl phosphonate oligonucleotide from topical formulations.", PHARMACEUTICAL RESEARCH (NEW YORK) 10 (10 SUPPL.). S252. ABSTRACT PDD7310, October 1993 (1993-10-01), XP002021246 & AAPS (AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS) EIGHTH ANNUAL MEETING AND EXPOSITION, ORLANDO, FLORIDA, USA, NOVEMBER 14-18, 1993.
  • See references of WO 9324134A1

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9324134 A1 19931209; AU 4388993 A 19931230; CA 2136349 A1 19931209; EP 0644765 A1 19950329; EP 0644765 A4 19970226; IL 105741 A0 19930922; JP H07508977 A 19951005; KR 950701528 A 19950428; MX 9302951 A 19940729; NZ 253509 A 19990929

DOCDB simple family (application)

US 9304917 W 19930521; AU 4388993 A 19930521; CA 2136349 A 19930521; EP 93914110 A 19930521; IL 10574193 A 19930519; JP 50069494 A 19930521; KR 19940704197 A 19941122; MX 9302951 A 19930520; NZ 25350993 A 19930521